Sugi Predict

Sugi Predict / Compounds / SCHEMBL23273237

SCHEMBL23273237

SCHEMBL23273237

CC(NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(N)CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(N)=O)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 9/20 0.45
▸ NPY4R P50391 6/20 0.42
▸ NPY1R P25929 5/20 0.42
▸ NPY2R P49146 4/20 0.42
▸ NPY5R Q15761 4/20 0.42
▸ CTSD P07339 3/20 0.42
▸ VIPR1 P32241 1/20 0.41
▸ TFPI P10646 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20764543 0.99 BACE1 (0.46) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL29966040 0.92 GNPAT (0.42) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL29486953 0.91 BACE1 (0.49) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL31031537 0.91 NPY4R (0.44) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30263724 0.91 NPY4R (0.48) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL23273242 0.90 TFPI (0.44) NPY4RNPY1RNPY5RVIPR1TFPI
SCHEMBL31031554 0.90 BACE1 (0.43) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL29594832 0.90 NPY4R (0.43) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL31157698 0.89 BACE1 (0.45) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30568069 0.89 NPY4R (0.44) BACE1NPY4RNPY1RNPY2RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911451-B2 Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers ImmuLogix Ltd (US) 2024-02-27 — — US disclosed
US-20210121546-A1 COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS ImmuLogix Ltd (US) 2021-04-29 — — US disclosed
Send feedback